News

Published on 14 Nov 2024 on GuruFocus.com · via Yahoo Finance

Mario Gabelli's Strategic Exits and Acquisitions in Q3 2024: Spotlight on...


Article preview image

Insights into Gabelli's Latest 13F Filings and Investment Shifts Mario J. Gabelli, a distinguished...

NYSE.INVX price evolution
NYSE.DRQ price evolution
NYSE.CR price evolution
NASDAQ.ACCD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Accolade, Inc. (ACCD) the Hottest Smid-Cap Stock So Far In 2025?

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we...

Insider Monkey · via Yahoo Finance 22 Jan 2025

Accolade, Inc. (NASDAQ:ACCD) Sees Significant Increase in Short Interest

Accolade, Inc. (NASDAQ:ACCD – Get Free Report) was the target of a significant increase in short...

ETF DAILY NEWS 20 Jan 2025

Brokerages Set Accolade, Inc. (NASDAQ:ACCD) Price Target at $7.55

Shares of Accolade, Inc. (NASDAQ:ACCD – Get Free Report) have received an average recommendation ...

ETF DAILY NEWS 20 Jan 2025

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not...

On Friday, Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM, CRISP...

Benzinga 18 Jan 2025

POET Technologies Inc. (POET): AI in Photonics Innovations

We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In...

Insider Monkey · via Yahoo Finance 17 Jan 2025

Raymond James Reiterates “Market Perform” Rating for Accolade (NASDAQ:ACCD)

Accolade (NASDAQ:ACCD – Get Free Report)‘s stock had its “market perform” rating restated by...

ETF DAILY NEWS 11 Jan 2025

Accolade (ACCD) Reports Q3 Loss, Lags Revenue Estimates

Accolade (ACCD) delivered earnings and revenue surprises of 3.23% and 0.89%, respectively, for th...

Zacks · via Yahoo Finance 10 Jan 2025

Accolade (NASDAQ:ACCD) Receives Market Perform Rating from Leerink Partners

Accolade (NASDAQ:ACCD – Get Free Report)‘s stock had its “market perform” rating restated by stoc...

ETF DAILY NEWS 10 Jan 2025

Johnson&Johnson, UnitedHealth lead Thursday's market cap stock movers By...

Johnson&Johnson, UnitedHealth lead Thursday's market cap stock movers

Investing.com 10 Jan 2025

Seattle health care company to go private in $621 million acquisition deal -...

Seattle-based health care company Accolade Inc. (Nasaq: ACCD) is being acquired by telehealth...

The Business Journals 8 Jan 2025